The floodplain soils are often heavily enriched in metal(loid)s released from the industrial areas. A related environmental risk depends on their total concentrations and the forms and conditions conducive to mobilization. This study was aimed to examine the concentrations of metal(loid)s in the Odra floodplain soils and to assess the risk associated with their possible contamination. In this study, topsoil and deeper soil layer samples were collected from the inter- and out-of-embankment zones. Total concentrations of Pb, Zn, Cu, As, Mn and Fe, and their extractable fractions were determined in 1 M NH4NO3 (actual solubility) and by BCR sequential extraction. The environmental risk was assessed based on total concentrations, according to legal regulations, geochemical enrichment indices and extractability of elements, with considering soil morphological features. Some topsoil samples from the inter-embankment zone turned out considerably enriched in Pb, Zn, Cu, and As, as confirmed by geochemical indices. Zn and As concentrations in some samples exceeded the permissible values defined by Polish law. Zn and Mn showed a high actual solubility, but a simple experiment proved that it can be efficiently reduced by liming. BCR fractionation showed that all the elements occurred mainly in reducible forms. Therefore, the risk of their release from the layers that do not indicate redoximorphic features was assessed as negligible. The study showed that such a complementary approach is needed to assess the real environmental risk in the case of soils considerably enriched in potentially toxic elements.

UNASSIGNED: Among men, prostate cancer (PCa) is one of the most commonly diagnosed cancers and the leading cause of cancer death worldwide. Phosphatase and tension homolog (PTEN) acts as a negative regulator of the phosphatidylinositol 3-kinase (PIK3)/Akt pathway and suppresses tumor progression. Meanwhile, PTEN is frequently deleted in PCa. Identifying the specific molecular markers of biochemical recurrence (BCR) in PCa patients is critical in clinical practice. Our systematic review summarizes the evidence about the PTEN expression and BCR rate in PCa patients.
UNASSIGNED: To clarify the impact of PTEN expression on the PCa BCR rate, a systematic review and meta-analysis was performed by searching the PubMed, Embase, and Web of Science databases, to identify the relevant literature. The analysis of pooled data was performed with Stata 12. The combined odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were evaluated by the fixed-effects or random-effects models. The combined sensitivity and publication bias were also estimated.
UNASSIGNED: In total, nine articles containing ten independent cohort studies, including 2,154 cases with positive expression of PTEN and 1,006 PTEN deletion cases, were deemed eligible for the meta-analysis. Overall, the positive expression of PTEN was associated with a significantly lower BCR rate (OR =0.521, 95% CI: 0.431-0.630). Subgroup analysis stratified by race revealed that in multiple races (OR =0.215, 95% CI: 0.072-0.648) and Caucasian (OR =0.469, 95% CI: 0.373-0.591) races, positive expression of PTEN showed a significant association with lower BCR rate. Subgroup analysis also showed the significant result in different sample sizes.
UNASSIGNED: PTEN deletion has a relationship with a higher BCR rate in PCa compared with positive expression of PTEN.